公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1999 | Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial? | RUEY-LONG HONG ; Huang C.-J.; Tseng Y.-L.; VICTOR FEI PANG ; Chen S.-T.; Liu J.-J.; FU-HSIUNG CHANG | Clinical Cancer Research | | | |
2020 | Discovery of novel agents on spindle assembly checkpoint to sensitize vinorelbine-induced mitotic cell death against human non-small cell lung cancers | Chang Y.-C.; Tseng Y.-L.; Leu W.-J.; Du C.-M.; Jiang Y.-H.; LIH-CHING HSU ; Hsu J.-L.; Hou D.-R.; JIH-HWA GUH | International Journal of Molecular Sciences | 2 | 1 | |
2004 | Effects of a snake venom metalloproteinase, triflamp, on platelet aggregation, platelet-neutrophil and neutrophil-neutrophil interactions: Involvement of platelet GPlbalpha and neutrophil PSGL-I | Tseng Y.-L.; Lee C.-J.; TUR-FU HUANG | Thrombosis and Haemostasis | 20 | 18 | |
2003 | Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody | Lee C.-H.; Hsiao M.; Tseng Y.-L.; FU-HSIUNG CHANG | Journal of Biomedical Science | 18 | 16 | |
2012 | Gallic acid attenuates platelet activation and platelet-leukocyte aggregation: Involving pathways of Akt and GSK3β | Chang S.-S.; Lee V.S.Y.; Tseng Y.-L.; Chang K.-C.; Chen K.-B.; YUH-LIEN CHEN ; Li C.-Y. | Evidence-based Complementary and Alternative Medicine | 45 | 33 | |
2019 | High concentration of C5a-induced mitochondria-dependent apoptosis in murine kidney endothelial cells | I-JUNG TSAI ; WEI-CHOU LIN ; YAO-HSU YANG ; Tseng Y.-L.; YEN-HUNG LIN ; Chou C.-H.; Tsau Y.-K. | International Journal of Molecular Sciences | 12 | 11 | |
2011 | High efficient driving circuit for traveling wave dielectrophoretic pump | Tseng Y.-L.; Huang C.-W.; U LEI ; Lin C.-W. ; FU-SHAN JAW | Measurement: Journal of the International Measurement Confederation | 5 | 5 | |
2008 | Human Leukocyte Antigen-DR Matching Improved Skin Graft Survival From Transgenic Pigs to Accommodate SCID Mice Reconstituted With Human Peripheral Blood Mononuclear Cells | Tu C.-F.; HAO-CHIH TAI ; Chen C.-M.; Huang T.-T.; JANG-MING LEE ; Yang T.-S.; Chen C.-H.; Tseng Y.-L.; NAI-KUAN CHOU ; PO-HUANG LEE | Transplantation Proceedings | 2 | 1 | |
2011 | Improvements in endotoxemic syndromes using a disintegrin, rhodostomin, through integrin alphav beta 3-dependent pathway | Hsu C.-C.; Chuang W.-J.; Chang C.-H.; Tseng Y.-L.; Peng H.-C.; TUR-FU HUANG | Journal of Thrombosis and Haemostasis | 19 | 19 | |
2010 | The in vitro protection of human decay accelerating factor and hDAF/heme oxygenase-1 transgenes in porcine aortic endothelial cells against sera of formosan macaques | Tu C.-F.; HAO-CHIH TAI ; Wu C.-P.; Ho L.-L.; Lin Y.-J.; Hwang C.-S.; Yang T.-S.; JANG-MING LEE ; Tseng Y.-L.; Huang C.-C.; Weng C.-N.; PO-HUANG LEE | Transplantation Proceedings | 6 | 5 | |
2017 | Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study | MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; Yang S.-H.; Tseng Y.-L.; Wu C.-F. | Gastroenterology | 129 | 117 | |
2004 | Inhibitory effects of human alpha2-macroglobulin and mouse serum on the PSGL-1 and glycoprotein Ib proteolysis by a snake venom metalloproteinase, triflamp | Tseng Y.-L.; Wu W.-B.; Hsu C.-C.; Peng H.-C.; TUR-FU HUANG | Toxicon | 10 | 9 | |
2008 | Long-Term Survival of HLA-DR15+ Pig Skin in SCID Mice After Reconstitution With Human Peripheral Blood Mononuclear Cells and Under Short-Term Immunosuppression | HAO-CHIH TAI ; Tu C.-F.; JANG-MING LEE ; Ho L.-L.; Tseng Y.-L.; NAI-KUAN CHOU ; Yang T.-S.; Weng C.-N.; PO-HUANG LEE ; KING-JEN CHANG ; Tang Y.-B. | Transplantation Proceedings | 1 | 1 | |
2004 | A novel peptide specifically binding to nasopharyngeal carcinoma for targeted drug delivery | Lee T.-Y.; Wu H.-C.; Tseng Y.-L.; CHIN-TARNG LIN | Cancer Research | 77 | 72 | |
2000 | Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study | RUEY-LONG HONG ; Tseng Y.-L.; FU-HSIUNG CHANG | Annals of Oncology | 22 | 19 | |
2001 | Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity | RUEY-LONG HONG ; Tseng Y.-L. | Cancer | 81 | | |
2012 | A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor | SHIH-HUNG YANG ; CHIA-CHI LIN ; ZHONG-ZHE LIN ; Tseng Y.-L.; RUEY-LONG HONG | Investigational New Drugs | 34 | 28 | |
2003 | A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma | RUEY-LONG HONG ; Tseng Y.-L. | Cancer Chemotherapy and Pharmacology | 41 | 38 | |
2004 | Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production | Tseng Y.-L.; Peng H.-C.; TUR-FU HUANG | Journal of Biomedical Science | 21 | 23 | |
2010 | A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation | Tseng Y.-L.; Chiang M.-L.; TUR-FU HUANG ; Su K.-P.; Lane H.-Y.; Lai Y.-C. | Thrombosis Research | 56 | 52 | |